11 March 2002
Credibility of problem-solving therapy and medication for the treatment of depression among primary care patients.
Laurence M Mynors-Wallis, Andrew M ThornettMed Sci Monit 2002; 8(3): CR193-196 :: ID: 420903
Abstract
BACKGROUND: Patient beliefs in the effectiveness of treatment may havean important influence on treatment outcome. MATERIAL/METHODS: Associations between patient beliefs inthe credibility of treatment and outcome were explored in a randomised controlled trial of major depressionin primary care (n=155). The four treatments were antidepressant medication given by research generalpractitioner, problem solving treatment given by research general practitioner or research practice nurseover 12 weeks or a combination of problem solving treatment and antidepressant medication. Patients'belief in the credibility of treatment was assessed using a brief Credibility Scale, that was completedfollowing randomisation and after treatment. Depression outcome was measured at 6, 12 and 52 weeks usingthe Hamilton Rating Scale for depression, and the Beck depression inventory. RESULTS: Pre-treatment,medication treatment was associated with a higher certainty of recovery than was problem-solving treatmentfrom the nurse (p=0.018). Post-treatment, medication and combination treatment were seen as more logicalthan problem-solving treatment from the nurse (p<0.03). Post-treatment medication had higher certainty of recovery and was more highly recommended to a friend. Linear regression demonstrated that the depression outcome measures were not associated with either pre- or post-treatment credibility.
Conclusions: Patients found all four treatments highly credible following their initial explanation. There was a significant difference both pre- and post-treatment in favour of patients finding treatment involving medication more credible than problem-solving from a nurse. Pre- and post-treatment scores of credibility were not associated with outcome
Keywords: Adolescent, Antidepressive Agents, Second-Generation, Depression, fluvoxamine, paroxetine, Psychotherapeutic Processes, Time Factors
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952